Back in May, leading developers of potential COVID-19 vaccines, including the biotechnology company Moderna and Oxford University, issued a ...
News
- The ethical case for allowing medical trials that deliberately infect humans with COVID-19
- Dillard's, Novavax rise; Baidu, DraftKings fall
The biotechnology company signed a deal to provide 60 million doses of a COVID-19 vaccine it's developing to the U.K.. Purple Innovation Inc., down ...
- Initial public offerings scheduled to debut next week
Harmony Biosciences Holdings - Plymouth Meeting, Pa., 4.7 million shares, priced $20-$23, managed by Goldman Sachs/Jefferies. Proposed Nasdaq ...
- Miami businessman pleads guilty in Vermont ski fraud case
Quiros, of Key Biscayne, Florida, and three others were indicted over a failed plan to build a biotechnology plant in Newport, Vermont, using millions ...
- Alert: Miami man pleads guilty of defrauding foreign investors in Vermont's largest fraud case, over ...
Alert: Miami man pleads guilty of defrauding foreign investors in Vermont's largest fraud case, over biotechnology plant plan. Updated 10:15 am CDT, ...